Skip to content

What is the number one weight loss drug in America?

4 min read

According to a May 2025 report from FAIR Health, more than 2% of U.S. adults took a GLP-1 medication for weight loss in 2024, highlighting the explosive demand for these treatments. Yet, determining what is the number one weight loss drug in America? is complex, as the answer depends on the criteria used to measure success, including prescription volume and clinical efficacy.

Quick Summary

The 'number one' weight loss drug is not clear-cut and depends on the metric. While older, cheaper drugs like phentermine are still widely prescribed, newer GLP-1 and dual-action agonists like Zepbound and Wegovy have proven more effective in producing significant weight loss.

Key Points

  • No Single 'Number One': There is no universal best weight loss drug; the most suitable option depends on individual factors like BMI, health conditions, and personal preferences.

  • Zepbound is Highly Effective: The dual-action drug Zepbound (tirzepatide) currently demonstrates the highest average weight loss (up to 22.5%) in clinical trials.

  • Popularity of Wegovy: Wegovy (semaglutide) is another highly popular and effective injectable, helping patients achieve about 15% weight loss on average.

  • Phentermine Remains Widely Prescribed: Despite being for short-term use, older and less costly drugs like phentermine are still commonly prescribed.

  • Lifestyle Changes are Crucial: All weight loss medications are most effective when combined with healthy diet and exercise habits.

  • Side Effects Vary Significantly: Newer GLP-1 drugs commonly cause gastrointestinal issues, while phentermine can cause cardiovascular effects. Patients must be aware of potential side effects.

  • Cost and Insurance Coverage are Major Barriers: Many newer, more effective drugs are very expensive and not always covered by insurance, which significantly impacts access.

In This Article

Determining the single 'number one' weight loss drug in America is a complicated question with no simple answer. The perception of which drug holds the top spot can vary depending on different factors, such as overall effectiveness, prescription volume, and media buzz. While newer, highly effective injectable medications like Zepbound and Wegovy have dominated headlines and demonstrated the most significant weight loss in clinical trials, older and less costly oral medications like phentermine remain widely prescribed. A patient's unique health profile, the amount of weight they need to lose, and potential side effects all influence a healthcare provider's final recommendation.

Understanding the Most Effective Injectables

For many looking for the most significant weight loss, the most effective medications are glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) agonists. These are typically administered as weekly injections and work by slowing digestion and increasing feelings of fullness, which helps reduce overall caloric intake.

Zepbound (Tirzepatide): The Highest Efficacy

As of mid-2025, Zepbound is often cited as the most effective weight loss medication. It contains the active ingredient tirzepatide, a dual-action agonist that mimics two different naturally occurring hormones (GIP and GLP-1). In clinical trials, adults on higher doses of Zepbound experienced an average weight loss of up to 22.5% over 72 weeks, surpassing the results of other similar medications. It was approved by the FDA for chronic weight management in November 2023.

Wegovy (Semaglutide): A Popular Contender

Another highly effective injectable is Wegovy, which contains the active ingredient semaglutide, a GLP-1 receptor agonist. It was approved for chronic weight management in June 2021 and has gained immense popularity. Studies show that patients on Wegovy can achieve an average weight loss of around 15%. Both Zepbound and Wegovy require a prescription and are generally used for long-term weight management in conjunction with diet and exercise.

The Role of Older Medications

Despite the rise of newer injectables, several older medications continue to be prescribed, often for their lower cost or specific applications.

Phentermine: A Long History

Phentermine is one of the oldest and most widely used weight loss medications, typically prescribed for short-term use. It is an appetite suppressant and, while effective, is a controlled substance due to its potential for abuse and dependence. Some studies suggest it can lead to about 5% weight loss.

Combination Pills: Qsymia and Contrave

  • Qsymia (Phentermine-Topiramate): Combines the appetite suppressant phentermine with the anti-seizure medication topiramate, which together reduce appetite and increase feelings of fullness. Clinical trials indicate an average weight loss of 7% to 11%.
  • Contrave (Naltrexone-Bupropion): Uses a combination of two drugs to target the brain's reward system, affecting cravings and appetite. It may help patients lose 5% to 10% of their body weight.

Orlistat: The Fat Inhibitor

Orlistat (brand names Xenical, and a lower-dose OTC version Alli) works differently by blocking the absorption of dietary fat. In studies, it has shown more modest weight loss results compared to other prescription options.

Comparison of Prominent Weight Loss Drugs

Feature Zepbound (Tirzepatide) Wegovy (Semaglutide) Phentermine Qsymia (Phentermine/Topiramate) Contrave (Naltrexone/Bupropion)
Drug Type Dual GIP/GLP-1 Agonist GLP-1 Agonist Stimulant/Appetite Suppressant Combination Pill Combination Pill
Administration Once-weekly injection Once-weekly injection Daily pill Once-daily capsule Twice-daily pill
Avg. Weight Loss Up to 22.5% Up to 15% ~5% 7%–11% 5%–10%
FDA Status Long-term weight mgmt. Long-term weight mgmt. Short-term weight loss Long-term weight mgmt. Long-term weight mgmt.
Common Side Effects GI issues (nausea, diarrhea, vomiting) GI issues (nausea, diarrhea, vomiting) Increased heart rate, insomnia, dry mouth Altered taste, numbness, dry mouth Nausea, constipation, headache, dizziness
Insurance Coverage Varies widely, can be very costly Varies widely, can be very costly Generally more accessible Varies Varies

Considerations for Choosing a Medication

Choosing a weight loss medication is a highly individualized process that involves a comprehensive assessment by a healthcare provider. Key factors include BMI, coexisting health conditions, and a history of previous weight loss attempts. For instance, a patient with heart disease may be a strong candidate for Wegovy, which has proven cardiovascular benefits, while those with a lower BMI or who prefer an oral option may explore other medications. Eligibility for GLP-1 medications typically requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes, or sleep apnea.

It is also crucial to remember that no weight loss medication is a "magic bullet." For the most effective and sustainable results, these drugs must be used in combination with significant lifestyle changes, including a balanced, nutrient-dense diet and regular physical activity. A healthcare team, including a registered dietitian, can help tailor a nutritional plan to maximize the medication's effectiveness while managing potential side effects.

Conclusion: The Best Drug is a Personal Choice

Ultimately, there is no single number one weight loss drug in America for everyone. The best medication is the one that is most effective and safest for an individual's specific health needs and goals, as determined by a healthcare provider. While newer injectables like Zepbound and Wegovy have demonstrated unparalleled efficacy in recent years, older and more established medications continue to serve as viable options for many patients. The decision should always be made after a careful medical evaluation, considering effectiveness, side effects, cost, and a patient's commitment to accompanying lifestyle changes.


  • Disclaimer: This information is for educational purposes only and is not medical advice. Consult with a qualified healthcare professional before starting or stopping any medication. For more information, visit the Obesity Medicine Association.*

Frequently Asked Questions

As of mid-2025, Zepbound (tirzepatide) is often cited as the most effective weight loss medication based on clinical trial data, with patients experiencing up to 22.5% average weight reduction.

No, Ozempic (semaglutide) is FDA-approved to treat type 2 diabetes. However, its sister drug, Wegovy, contains the same active ingredient but is approved for chronic weight management and is prescribed at a higher dose for weight loss.

GLP-1 drugs work by mimicking a hormone that regulates appetite and slows down stomach emptying. This helps you feel fuller for longer, reduces hunger cues, and decreases overall calorie intake.

Eligibility typically requires a Body Mass Index (BMI) of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related health condition like high blood pressure, type 2 diabetes, or sleep apnea.

Common side effects for GLP-1 agonists like Zepbound and Wegovy primarily involve gastrointestinal issues, including nausea, vomiting, diarrhea, constipation, and abdominal pain.

For most patients, weight loss medications are intended for long-term use. Weight regain is common if the medication is stopped, and continued use alongside lifestyle changes is recommended to maintain the benefits.

Yes, phentermine remains one of the most widely used weight loss medications, largely due to its lower cost. However, it is typically prescribed for short-term use due to potential side effects.

No, clinical trials consistently show that newer injectable medications like Zepbound and Wegovy produce significantly higher average weight loss percentages than existing oral weight loss pills.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.